H Ishikawa

PolyU tail of rho-independent terminator of bacterial small RNAs is essential for Hfq action

Hironori Otaka, H Ishikawa, Teppei Morita et al. · Proceedings of the National Academy of Sciences · 2011 · 192 citations · Full text

Engineering, Molecular Biology, Target Mrnas +18

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist

Kiyoshi Arai, Tsuyoshi Homma, Yuka Morikawa et al. · European Journal of Pharmacology · 2015 · 132 citations

Physiology, Pharmacology, Pharmacological Agent +6

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

Nobuya Kurikawa, Miwa Suga, Shoko Kuroda et al. · British Journal of Pharmacology · 2003 · 127 citations · Full text

The functional Hfq-binding module of bacterial sRNAs consists of a double or single hairpin preceded by a U-rich sequence and followed by a 3′ poly(U) tail

H Ishikawa, Hironori Otaka, Kimika Maki et al. · RNA · 2012 · 123 citations · Full text

Combined effects of TNP-470 and taxol in human non-small cell lung cancer cell lines.

Hiroaki Satoh, H Ishikawa, Masanori Fujimoto et al. · PubMed · 1998 · 25 citations

Chemoprevention Strategy, Sequential Exposure, Pathology +18